A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Context Therapeutics Inc.’s current trading price is -68.65% away from its 52-week high, while its distance from the 52-week low is 68.09%. The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months.
Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79. The stock saw a sharp increase in the last trading session, hitting a high of $0.91 after opening at $0.6771. The lowest recorded price for the day was $0.6406 before it closed at $0.70.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Context Therapeutics Inc.’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $2.52 on 06/23/22, and the lowest price during that time was $0.47, recorded on 05/15/23.
How Financial Performance Impacts Market Capitalization
Context Therapeutics Inc. (CNTX) has experienced a quarterly decline of -0.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 10.83M and boasts a workforce of 9 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6961, with a change in price of +0.1609. Similarly, Context Therapeutics Inc. recorded 1,282,773 in trading volume during the last 100 days, posting a change of +25.58%.
How CNTX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CNTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CNTX Stock Stochastic Average
Context Therapeutics Inc.’s raw stochastic average for the past 50 days is currently at 72.73%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 72.73%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 86.47% and 86.95%, respectively.
CNTX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a gain of 21.22%.However, over the last six months, we can see a stronger performance of -37.80%. Over the last 30 days, the price of CNTX has fallen by 36.99%. And in the last five days, it has surged by 44.64%.